Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    CANGENE CORPORATION

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Cangene Corporation

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-06-21

    CANGENE CORPORATION

    City : Winnipeg

    State :

    Country/Area : CA

    Zip :

    District : ORA

    Center : CBER

    Project Area : Blood and Blood Products

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-06-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-07-18

    CANGENE CORPORATION

    City : Winnipeg

    State :

    Country/Area : CA

    Zip :

    District : ORA

    Center : CBER

    Project Area : Blood and Blood Products

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-07-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-02-03

    CANGENE CORPORATION

    City : Winnipeg

    State :

    Country/Area : CA

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-02-03

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-04-22

    CANGENE CORPORATION

    City : Winnipeg

    State :

    Country/Area : CA

    Zip :

    District : ORA

    Center : CBER

    Project Area : Blood and Blood Products

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-04-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-10-19

    CANGENE CORPORATION

    City : Winnipeg

    State :

    Country/Area : CA

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-10-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow